Quest Diagnostics stock after-hours at EUR 206.05
Published on 10/02/2026 at 21:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Quest Diagnostics stock is at EUR 206.05 in after-hours trading at 9:48 p.m. CEST on October 2, 2026, according to Lang & Schwarz.
Quest Diagnostics stock in after-hours trading
The Lang & Schwarz quote represents the latest euro indication for Quest Diagnostics after the Xetra close. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Quest Diagnostics stock.
Haystack MRD study reports clinical results
In a release dated October 1, Quest Diagnostics said a study published in The Journal of Molecular Diagnostics evaluated its Haystack MRD test using specimens from the DYNAMIC and DYNAMIC-III colorectal cancer trials. The company reported 100% sensitivity and 100% specificity at three-year follow-up, and 83.3% sensitivity and 100% specificity at five-year follow-up. The study also validated analytical performance across 23 solid tumor types, according to PR Newswire.
Third-quarter results set for October 22
Quest Diagnostics said it will release its third-quarter 2026 financial results before the market opens on October 22, 2026. The company plans to hold its earnings conference call at 8:30 a.m. Eastern Time that day, according to its investor-relations release.
